期刊文献+

异基因造血干细胞移植治疗进展期慢性髓性白血病——非血缘脐血与同胞供者移植的疗效分析 被引量:1

Allogeneic hematopoietic stem cell transplantation for aggressive-phase chronic myeloid leukemia--outcomes of unrelated umbilical cord blood and sibling donor
原文传递
导出
摘要 由于酪氨酸激酶抑制剂(TKI)近期疗效较好且毒性低,伊马替尼自问世以来很快成为慢性髓性白血病(cML)一线治疗的选择。但对于TKI治疗失败和包含T315I突变及进展期的CML患者,造血干细胞移植(HSCT)不失为一种有效的治疗方法。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第3期253-255,共3页 Chinese Journal of Hematology
基金 安徽省十二五科技攻关项目(11010402164)
  • 相关文献

参考文献13

  • 1Moen MD, McKeage K, Plosker GL, et al. Imatinib: a review of its use in chronic myeloid leukaemia IJl. Drugs, 2007, 67 (2): 299-320.
  • 2Hehlmann R, Berger U, Pfirrmann M, et al. Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia[ J ]. Blood, 2007, 109 ( 11 ) :4686-4692.
  • 3Gratwohl A, Heim D. Current role of stem cell transplantation in chronic myeloid leukaemia [J]. Best Pract Res Clin Haematol, 2009, 22(3):431-443.
  • 4Weisser M, Ledderose G, Jochem Kolb H. Long-term follow-up of allogeneic HSCT for CML reveals significant improvement in the outcome over the last decade [J]. Ann Hematol, 2007, 86 (2):127-132.
  • 5Koh LP, Hwang WY, Tan CH, et al. Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT).from HLA- identical sibling- evaluation of risks and benefits [ J ]. Ann Hematol, 2004, 83(5): 286-294.
  • 6Sanz J, Sanz GF. Umbilical cord blood transplantation from unre- lated donors in adult patients with chronic myeloid leukaemia [J]. Best Pract Res Clin Haematol, 2010, 23(2): 217-222.
  • 7Khoury HJ, Kukreja M, Goldman JM, et al. Prognostic factors for outcomes in allogeneic transplantation for CML in the ima- tinib era: a CIBMTR analysis [J]. Bone Marrow Transplant, 2012, 47(6): 810-816.
  • 8McGlave PB, Shu XO, Wen W, et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' expe- rience of the national marrow donor program [J]. Blood, 2000, 95(7):2219-2225.
  • 9Papadakis V, Mackinnon S, Keman NA. Differential effect of pre-transplant cytoreduction on recovery of day zero host circu- lating cells[J]. Bone Marrow Transplant, 1994, 14(4):623-630.
  • 10Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical- cord blood or bone marrow from unrelated donors in adults with acute leukemia[ J ]. N Engl J Med, 2004, 351 (22) :2276-2285.

同被引文献4

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部